Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED BALANCE SHEETS

v3.25.4
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 3,186 $ 527
Accounts receivable, net 22,901 21,155
Inventories, net 5,391 6,528
Other current assets 4,858 3,955
Total current assets 36,336 32,165
Medical equipment for sale or rental 4,589 3,157
Medical equipment in rental service, net of accumulated depreciation 34,456 39,175
Property & equipment, net of accumulated depreciation 3,359 4,030
Goodwill 3,710 3,710
Intangible assets, net 6,866 6,456
Operating lease right of use assets 4,178 5,374
Deferred income taxes 4,640 7,188
Derivative financial instruments 748 1,481
Other assets 1,678 878
Total assets 100,560 103,614
Current liabilities:    
Accounts payable 10,821 9,848
Other current liabilities 9,361 7,813
Total current liabilities 20,182 17,661
Long-term debt, net of current portion 19,625 23,864
Operating lease liabilities, net of current portion 3,427 4,560
Total liabilities 43,234 46,085
Stockholders’ equity:    
Preferred stock, $0.0001 par value: authorized 1,000,000 shares; none issued 0 0
Common stock, $0.0001 par value: authorized 200,000,000 shares; 20,209,636 shares issued and outstanding as of December 31, 2025 and 21,272,351 shares issued and outstanding as of December 31, 2024 2 2
Additional paid-in capital 117,461 113,868
Accumulated other comprehensive income 565 1,119
Retained deficit (60,702) (57,460)
Total stockholders’ equity 57,326 57,529
Total liabilities and stockholders’ equity $ 100,560 $ 103,614